A nurse is reviewing the medical record for a child who is scheduled to receive a varicella immunization. Which of the following findings in the client's record should the nurse recognize as a contraindication?

After a laparoscopic cholecystectomy, steri-strips or adhesive strips are commonly placed over the small incisions. The client should keep the steri-strips in place until they fall off on their own or until they are removed by the healthcare provider during a follow-up visit. Removing the steri-strips prematurely can increase the risk of infection or disrupt the healing process.

"I should eat a high-fat diet for several weeks": After a laparoscopic cholecystectomy, it is important for the client to follow a low-fat diet initially to allow the body time to adjust to the absence of the gallbladder. High-fat foods can be more difficult to digest and may cause digestive discomfort. Gradually introducing small amounts of fat back into the diet is recommended, but a high-fat diet is not appropriate.

"I should expect to have diarrhea until my diet changes": While changes in bowel movements can occur after a cholecystectomy, such as looser stools or changes in frequency, persistent diarrhea is not expected or normal. If the client experiences persistent diarrhea, they should contact their healthcare provider for further evaluation.

"I should expect to have nausea for several days": While some clients may experience mild nausea or discomfort after the surgery, it should generally improve within a few days. If the client experiences persistent or severe nausea, they should contact their healthcare provider.

Monitoring the infant's lymphocyte count is important in evaluating the immune function of the infant. HIV primarily affects the immune system, including lymphocytes. Monitoring the lymphocyte count helps assess the progression of the disease and the effectiveness of treatment.

Exchange transfusions are not typically used in the management of HIV. They are primarily performed in conditions like severe neonatal jaundice or blood disorders, but not for the treatment of HIV.

Granulocyte colony-stimulating factor (G-CSF) is a medication used to stimulate the production of white blood cells called granulocytes. While G-CSF can be used in certain situations, such as to counteract the side effects of certain chemotherapy drugs, it is not a standard treatment for HIV in infants.

Droplet precautions are typically implemented for infectious diseases that spread through respiratory droplets, such as influenza or respiratory syncytial virus (RSV). HIV does not spread through respiratory droplets, so initiating droplet precautions would not be necessary in the care of an infant with HIV.